person
as of 2026-07-01Margaret K Hahn, PhD, MD
Margaret HahnMargaret Hahn, MD, PhDMargaret Hahn, PhD, MD
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 10
2 publications · 1 high-value
Cross-drug reach: 1 competitor drugs
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Centre for Addiction and Mental Health
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
10
Publications
2 (1 high-value)
Trial investigator
yes
Publishes on
1 drugs
Trials led
4
Topiramate and Schizophrenia: Effects on Weight and Psychopathology
NCT02808533—Active Not Recruiting
Gut Microbiome in AP Naive
NCT03414151—Active Not Recruiting
Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity
NCT05333003—Active Not Recruiting
Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness
NCT02167620Phase 4Completed
Publications & congress
2
Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of Psychosis.
Schizophrenia bulletin · 2026 · high-value
From brain bioenergetics to hypothalamic glucoregulation: A shared-systems hypothesis for intrinsic dysglycemia in schizophrenia.
Reviews in endocrine & metabolic disorders · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
publishes on
drug